Intelligent Asthma Monitoring Devices Market to Reach $655 Mn, Globally, by 2025 at 54.5% CAGR, Says AMR
PORTLAND, Oregon, January 22, 2019 /PRNewswire/ --
Surge in prevalence of COPD and asthma and increase in adoption of smart inhalers are
expected to propel the growth of the intelligent asthma monitoring devices market
Allied Market Research published a report, titled, "Intelligent Asthma Monitoring Devices Market [https://www.alliedmarketresearch.com/intelligent-asthma-monitoring-devices-market ] by Product (Wearable Asthma Monitoring Devices, and Smart Inhalers) and End User (Hospitals, Clinics, and Home Use): Global Opportunity Analysis and Industry Forecast, 2018-2025". The report offers in-depth analyses of the market size & estimations, key player positioning, drivers & opportunities, major market segments, top-winning strategies, and competitive landscape. According to the report, the global intelligent asthma monitoring devices market accounted for $20 million in 2017 and is expected to reach $655 million by 2025, registering a CAGR of 54.5% through 2025.
(Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg )
Increase in indoor air pollutants, rise in prevalence of chronic obstructive pulmonary disease (COPD) and asthma, and surge in adoption of smart inhalers drive the growth of the global intelligent asthma monitoring devices market. However, concerns about data privacy hamper the market growth. On the contrary, increased focus toward advanced treatment protocols and unmet needs in respiratory care across developing countries are expected to create lucrative opportunities for the market players in the near future.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5124
Smart inhalers segment to be lucrative through 2025
Smart inhalers segment held the largest share in 2017, contributing more than four-fifths of the total market revenue. Moreover, the segment is expected to manifest the fastest CAGR of 57.0% during the forecast period because these devices are used for monitoring drug dose and improving drug administration time to identify asthma attack and avoid further complications. The other segment of wearable asthma is also analyzed in the report.
Home use segment to retain largest share through 2025
The home use segment is register the fastest CAGR of 53.8% from 2018 to 2025, as these products are user-friendly, help avoid severe attack due to real-time monitoring, and assist in drug dose and time of medication. However, hospitals segment held the largest share in 2017, contributing about two-fifths of total revenue, as it offers basic services for asthma monitoring along with availability of skilled nurses and trained professionals.
Get Upto 25% Discount (valid till 31 Jan'19)
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/5124
Asia-Pacific to grow the fastest through 2025
Asia-Pacific region is projected to grow at the fastest CAGR of 56.7% through 2025, owing to presence of high patient base, increase in healthcare expenditure by the populace, and technology advancements to launch cost-effective devices. However, North America held the largest share in 2017, contributing more than two-fifths of the total market revenue, owing to increased awareness about intelligent asthma monitoring devices among healthcare professionals & patients, availability of trained healthcare personnel, and high reimbursement policies. The other regions analyzed in the report include Europe and Latin America, Middle East and Africa (LAMEA).
Major market players
The key market players analyzed in the report include Vectura Group plc, Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations), Qualcomm Life, Health Care Originals, GlaxoSmithKline plc, Propeller Health, Adherium Limited, AstraZeneca plc, Philips Healthcare, and Volansys Technologies.
Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree
Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas.
Similar Reports:
Asthma and COPD Drugs Market - Global Opportunity Analysis and Industry Forecast, 2016 - 2022 [https://www.alliedmarketresearch.com/asthma-COPD-drug-market ]
South Asia Flexible Endoscope Market - Opportunity Analysis and Industry Forecast, 2018 - 2025 [https://www.alliedmarketresearch.com/south-asia-flexible-endoscope-market ]
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Photo:
https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
SOURCE Allied Market Research
